This guide explains published facts and prices. It is not medical advice: a licensed provider who knows your health history decides what is right for you.
What is GLP-1 medication?
Drug labels call these medicines GLP-1 receptor agonists. The Wegovy label notes that the GLP-1 receptor is present in several areas of the brain involved in appetite regulation (Wegovy prescribing information).
Tirzepatide works on a second receptor as well: the Zepbound label says it binds to and activates both the GIP and GLP-1 receptors (Zepbound prescribing information). What that second receptor may add is covered in what is tirzepatide, and how the two medicines compare in semaglutide or tirzepatide.
Which brands are semaglutide and tirzepatide?
Semaglutide and tirzepatide are the two medications our Georgia price ranges cover. Each one has more than one brand name, and each brand has its own label. In short, here is what each label says it is approved for:
- Wegovy (semaglutide, injection or tablets): for reducing excess body weight and keeping it off, and for lowering the risk of major cardiovascular events, in certain people with obesity or overweight (Wegovy prescribing information).
- Ozempic (semaglutide, injection): for adults with type 2 diabetes (Ozempic prescribing information).
- Rybelsus and Ozempic tablets (semaglutide, tablets): for blood sugar control in adults with type 2 diabetes (Rybelsus and Ozempic tablets prescribing information).
- Zepbound (tirzepatide, injection): for reducing excess body weight and keeping it off in certain adults with obesity or overweight, and for moderate to severe obstructive sleep apnea in adults with obesity (Zepbound prescribing information).
- Mounjaro (tirzepatide, injection): for blood sugar control in adults and children 10 and older with type 2 diabetes (Mounjaro prescribing information).
Who exactly each brand is approved for, and how each one is taken, is in what is semaglutide and what is tirzepatide.
Is GLP-1 a peptide?
For semaglutide, the Wegovy label answers in its own words. It calls semaglutide a GLP-1 analogue with 94% sequence homology to human GLP-1, meaning its sequence is 94% similar to the body's own GLP-1, and it says the peptide backbone is produced by yeast fermentation (Wegovy prescribing information).
If any product is offered to you as a peptide, ask exactly what it is, whether it is FDA approved, and who prescribes it.
Is GLP-1 safe?
That is a judgment a licensed provider makes for one person, and the labels set out what goes into it. The Wegovy and Zepbound labels each carry a boxed warning about thyroid C-cell tumors: semaglutide caused them in rodents and tirzepatide in rats, and each label says it is unknown whether the medicine causes these tumors in humans, including medullary thyroid carcinoma (MTC), a type of thyroid cancer (Wegovy prescribing information; Zepbound prescribing information).
Both labels say the medicine must not be used by anyone with a personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Both also list nausea, diarrhea, vomiting, constipation and abdominal pain among the most common side effects, reported in at least 5% of patients (Wegovy prescribing information; Zepbound prescribing information).
Each label lists more warnings than these. For the full list on each one, see what is semaglutide and what is tirzepatide.
What about compounded GLP-1 medications?
Our Georgia ranges come from the prices med spas post, and a posted monthly price may not be for a brand-name product. Here is what FDA says about versions that are not FDA approved (FDA's concerns with unapproved GLP-1 drugs):
- Compounded drugs are not FDA approved, which means FDA does not review them for safety, effectiveness or quality before they are marketed.
- Unapproved versions do not go through FDA's review for safety, effectiveness and quality before they are marketed, and FDA says that can be risky for patients.
- FDA advises getting a prescription from your doctor and filling it at a state-licensed pharmacy.
So before you start, ask three things: is this the FDA-approved product or a compounded one, who prescribes it, and which pharmacy fills it? FDA's concerns about compounded semaglutide in particular are in what is semaglutide.
What does a month of GLP-1 injections cost in Georgia?
These are estimates from what Georgia med spas and skin clinics publish, not quotes, and we do not name any company. Med spas price these programs by the month:
- Semaglutide injections: estimated at $150 to $310+ per month.
- Tirzepatide injections: estimated at $230 to $400+ per month. See what a month of GLP-1 injections costs.
- Weight loss consultation, if one is charged: estimated at $75 to $100+. See what med spa consultations cost.
A month can cover the medication alone or the medication with visits and supplies, so check what each month includes before you compare prices.
Questions to ask your provider
- Which medication is this, and which brand, if any?
- Is it the FDA-approved product or a compounded one, and which pharmacy fills it?
- Which warnings on the label apply to me, given my health history?
- What does the monthly price include, and is a consultation fee credited toward it?
Ask for the medication's name and the full monthly price in writing, so you can compare programs on the same terms.
Sources
- Wegovy (semaglutide) injection and tablets, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
- Zepbound (tirzepatide) injection, FDA-approved prescribing information (Eli Lilly, label effective August 2026), DailyMed, National Library of Medicine
- Ozempic (semaglutide) injection, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
- Rybelsus and Ozempic (oral semaglutide) tablets, FDA-approved prescribing information (Novo Nordisk, label effective January 2026), DailyMed, National Library of Medicine
- Mounjaro (tirzepatide) injection, FDA-approved prescribing information (Eli Lilly, label effective August 2026), DailyMed, National Library of Medicine
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration
Prices mentioned here come from our Georgia med spa cost ranges, built from the prices and cost guides Georgia med spas publish on their public websites, collected September and October 2026.